Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 20

The DOI matches its Crossref record.

Cyclic AMP‐dependent protein kinase catalytic subunit A (PRKACA): the expected, the unexpected, and what might be next

Stratakis, Constantine A · 2018 · The Journal of Pathology

Abstract

Protein kinase A (PKA) or cyclic‐AMP (cAMP)‐dependent kinase was among the first serine–threonine kinases to be molecularly and functionally characterized. For years, it was investigated as the enzyme that mediates cAMP functions in almost all cell systems and organisms studied to date. Despite PKA's critical role in signaling and the long history of investigations of cAMP in oncogenesis (dating back to the 1970s), it was not until relatively recently that PKA defects were found to be directly involved in tumor predisposition. First, PKA's main regulatory subunit, PRKAR1A, was found to be mutated in Carney complex, a genetic syndrome that predisposes to heart tumors (cardiac myxomas) and a variety of other lesions of the endocrine system, including the adrenal cortex, and several cancers, including liver carcinoma. Then, PKA's main catalytic subunit, PRKACA, was found to be mutated in sporadic adrenal tumors and fibrolamellar liver carcinoma. Not surprisingly, therefore, a new research study published in The Journal of Pathology showed PRKACA mutations in sporadic cardiac myxomas. The real question is what other pathologies will be found to be due to PRKACA (or other PKA subunit) defects. The possibilities abound and may show the way for a totally new class of medications that target cAMP signaling to be useful in fighting the corresponding tumors. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/path.5014

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 22

  1. 10.1016/j.mce.2013.01.015 · DOI
  2. 10.1016/j.mce.2010.11.018 · DOI
  3. 10.1530/EJE-15-0209 · DOI · Paper page
  4. 10.1016/j.mce.2013.08.022 · DOI
  5. 10.1210/en.2004-0900 · DOI · Paper page
  6. 10.1056/NEJMoa1310359 · DOI · Paper page
  7. 10.1055/s-0042-120416 · DOI
  8. 10.1055/s-0042-112817 · DOI · Paper page
  9. 10.1002/path.4899 · DOI
  10. 10.1097/PAS.0000000000000202 · DOI
  11. 10.1073/pnas.89.10.4726 · DOI
  12. 10.1016/S0021-9258(18)53112-4 · DOI
  13. 10.1371/journal.pone.0004746 · DOI · Paper page
  14. 10.1371/journal.pone.0034838 · DOI
  15. 10.1530/eje.0.1410409 · doi:10.1530/eje.0.1410409
  16. 10.1210/jc.2014-3295 · DOI
  17. 10.1097/MED.0000000000000149 · DOI
  18. 10.1016/j.humpath.2014.09.005 · DOI
  19. 10.1530/EJE-14-1154 · DOI
  20. 10.1126/science.1249484 · DOI · Paper page
  21. 10.1038/onc.2014.153 · DOI
  22. 10.1210/me.16.3.630 · doi:10.1210/me.16.3.630

Cited by

See all 20

Metadata

Authors
Stratakis, C. A.
Affiliations
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH and Section on Endocrinology and Genetics (SEGEN) NICHD, NIH, Bethesda USA
Venue
The Journal of Pathology
Publisher
Wiley
Published
2018-01-02
Volume
244
Issue
3
Pages
257-259
ISSN
  • 0022-3417
  • 1096-9896
Cited by
20
References
0
Language
en
Funders
Eunice Kennedy Shriver National Institute of Child Health and Human Development

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cyclic AMP‐dependent protein kinase catalytic subunit A (PRKACA): the expected, the unexpected, and what might be next. https://app.cochat.ai/papers/10.1002/path.5014
The paper
Stratakis, C. A. (2018). Cyclic AMP‐dependent protein kinase catalytic subunit A (PRKACA): the expected, the unexpected, and what might be next. The Journal of Pathology. https://doi.org/10.1002/path.5014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.